Physician profile
Jack D Smith
NPI 1891780581
$5,339.63
in general payments reported to CMS, 2019-2025
8 companies · $4,257 in 2025
The $4,257 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.39 · 2023: $386 · 2024: $673 · 2025: $4,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,315.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $4,035.09 | 2023-2025 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $693.65 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $294.64 | 2024-2025 | Mild Device Kit |
| Abbott Laboratories | $161.12 | 2023 | Proclaim |
| Mml US, INC. | $45.82 | 2025 | Reactiv8 |
| Si-Bone, INC. | $44.63 | 2024-2025 | |
| Tg Therapeutics, INC. | $40.29 | 2024-2025 | |
| Pfizer INC. | $24.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.